Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott J Rodig

Showing results (61-70 of 293) with videos related to

Pageof 30
Sort By:
Blood|November 8, 2019
The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negativeSanjay S Patel, Jason L Weirather, Mikel Lipschitz, et al.
Brain : a Journal of Neurology|January 11, 2011
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosisLaura Lovato, Simon N Willis, Scott J Rodig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleenJavier Gordon Ogembo, Danny A Milner, Keith G Mansfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphomaPrzemyslaw Juszczynski, Jing Ouyang, Stefano Monti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 6, 2016
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunityScott C Bresler, Le Min, Scott J Rodig, et al.
The American Journal of Surgical Pathology|July 16, 2014
Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gainMin Shi, Margaretha G M Roemer, Bjoern Chapuy, et al.
Epidemiology (Cambridge, Mass.)|January 21, 2010
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of menKimberly A Bertrand, Donna Spiegelman, Jon C Aster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)Scott J Rodig, Jeremy S Abramson, Geraldine S Pinkus, et al.
The American Journal of Surgical Pathology|September 17, 2011
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomasSvetlana Kondratiev, Sekhar Duraisamy, Christine L Unitt, et al.
Blood|December 20, 2013
Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cellsSamuel G Katz, James L Labelle, Hailong Meng, et al.
Pageof 30

Showing results (61-70 of 293) with videos related to

Sort By:
Pageof 30
Blood|November 8, 2019
The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negativeSanjay S Patel, Jason L Weirather, Mikel Lipschitz, et al.
Brain : a Journal of Neurology|January 11, 2011
Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosisLaura Lovato, Simon N Willis, Scott J Rodig, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2012
SIRPα/CD172a and FHOD1 are unique markers of littoral cells, a recently evolved major cell population of red pulp of human spleenJavier Gordon Ogembo, Danny A Milner, Keith G Mansfield, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 3, 2007
The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphomaPrzemyslaw Juszczynski, Jing Ouyang, Stefano Monti, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|December 6, 2016
Gene expression profiling of anti-CTLA4-treated metastatic melanoma in patients with treatment-induced autoimmunityScott C Bresler, Le Min, Scott J Rodig, et al.
The American Journal of Surgical Pathology|July 16, 2014
Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gainMin Shi, Margaretha G M Roemer, Bjoern Chapuy, et al.
Epidemiology (Cambridge, Mass.)|January 21, 2010
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of menKimberly A Bertrand, Donna Spiegelman, Jon C Aster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Heterogeneous CD52 expression among hematologic neoplasms: implications for the use of alemtuzumab (CAMPATH-1H)Scott J Rodig, Jeremy S Abramson, Geraldine S Pinkus, et al.
The American Journal of Surgical Pathology|September 17, 2011
Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomasSvetlana Kondratiev, Sekhar Duraisamy, Christine L Unitt, et al.
Blood|December 20, 2013
Mantle cell lymphoma in cyclin D1 transgenic mice with Bim-deficient B cellsSamuel G Katz, James L Labelle, Hailong Meng, et al.
Pageof 30